Mingxiang Teng

7.6k total citations · 1 hit paper
64 papers, 3.2k citations indexed

About

Mingxiang Teng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mingxiang Teng has authored 64 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 15 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Mingxiang Teng's work include Viral-associated cancers and disorders (10 papers), Genomics and Chromatin Dynamics (9 papers) and Genomics and Phylogenetic Studies (8 papers). Mingxiang Teng is often cited by papers focused on Viral-associated cancers and disorders (10 papers), Genomics and Chromatin Dynamics (9 papers) and Genomics and Phylogenetic Studies (8 papers). Mingxiang Teng collaborates with scholars based in United States, China and United Kingdom. Mingxiang Teng's co-authors include Yadong Wang, Qinghua Jiang, Yangyang Hao, Guoxiu Wang, Juan Li, Yaohua Liu, Rafael A. Irizarry, Stephanie C. Hicks, F. William Townes and Yunlong Liu and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Mingxiang Teng

60 papers receiving 3.2k citations

Hit Papers

miR2Disease: a manually curated database for microRNA der... 2008 2026 2014 2020 2008 250 500 750 1000

Peers

Mingxiang Teng
Pankaj Kumar United States
Jean‐Pierre Kocher United States
Hailiang Mei Netherlands
Joshua C. Black United States
Pankaj Kumar United States
Mingxiang Teng
Citations per year, relative to Mingxiang Teng Mingxiang Teng (= 1×) peers Pankaj Kumar

Countries citing papers authored by Mingxiang Teng

Since Specialization
Citations

This map shows the geographic impact of Mingxiang Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxiang Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxiang Teng more than expected).

Fields of papers citing papers by Mingxiang Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxiang Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxiang Teng. The network helps show where Mingxiang Teng may publish in the future.

Co-authorship network of co-authors of Mingxiang Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Mingxiang Teng. A scholar is included among the top collaborators of Mingxiang Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingxiang Teng. Mingxiang Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shepard, Alyssa, Scott Troutman, Walid T. Khaled, et al.. (2025). An Autochthonous Model of Lung Cancer Identifies Requirements for Cellular Transformation in the Naked Mole Rat. Cancer Discovery. 16(1). 35–45. 1 indexed citations
3.
Manley, Brandon J., G. Daniel Grass, Dorina Avram, et al.. (2024). BatchFLEX: feature-level equalization of X-batch. Bioinformatics. 40(10).
4.
Gillis, Nancy, Christelle Colin, Ryan M. Putney, et al.. (2024). Clonal Hematopoiesis in Patients With Human Immunodeficiency Virus and Cancer. The Journal of Infectious Diseases. 230(3). 680–688. 3 indexed citations
5.
Gillis, Nancy, Eric Padron, Tao Wang, et al.. (2023). Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National Registry. Transplantation and Cellular Therapy. 29(10). 640.e1–640.e8. 4 indexed citations
6.
Colin, Christelle, Rahul Mhaskar, Shridar Ganesan, et al.. (2023). Clonal Hematopoiesis as a Molecular Risk Factor for Doxorubicin-Induced Cardiotoxicity: A Proof-of-Concept Study. JCO Precision Oncology. 7(7). e2300208–e2300208. 4 indexed citations
7.
Chang, Darwin, Mingxiang Teng, Aik Choon Tan, et al.. (2023). PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing. BMC Bioinformatics. 24(1). 266–266. 3 indexed citations
8.
Liu, Xiang, Bo Zhao, Timothy I. Shaw, et al.. (2022). Summarizing internal dynamics boosts differential analysis and functional interpretation of super enhancers. Nucleic Acids Research. 50(6). 3115–3127. 5 indexed citations
9.
Huang, Jinyong, Mingxiang Teng, İbrahim Halil Şahin, et al.. (2021). Cancer Detection and Classification by CpG Island Hypermethylation Signatures in Plasma Cell-Free DNA. Cancers. 13(22). 5611–5611. 11 indexed citations
10.
Wang, Zhonghao, Rui Guo, Stephen J. Trudeau, et al.. (2021). CYB561A3 is the key lysosomal iron reductase required for Burkitt B-cell growth and survival. Blood. 138(22). 2216–2230. 20 indexed citations
11.
Vena, Francesca, Simon Bayle, Ainhoa Nieto, et al.. (2020). Targeting Casein Kinase 1 Delta Sensitizes Pancreatic and Bladder Cancer Cells to Gemcitabine Treatment by Upregulating Deoxycytidine Kinase. Molecular Cancer Therapeutics. 19(8). 1623–1635. 8 indexed citations
12.
Wang, Chong, Luyao Zhang, Liang‐Ru Ke, et al.. (2020). Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors. Nature Communications. 11(1). 6318–6318. 24 indexed citations
13.
Guo, Rui, Yuchen Zhang, Mingxiang Teng, et al.. (2020). DNA methylation enzymes and PRC1 restrict B-cell Epstein–Barr virus oncoprotein expression. Nature Microbiology. 5(8). 1051–1063. 42 indexed citations
14.
Teng, Mingxiang & Rafael A. Irizarry. (2017). Accounting for GC-content bias reduces systematic errors and batch effects in ChIP-seq data. Genome Research. 27(11). 1930–1938. 19 indexed citations
15.
Nakayama, Robert, John L. Pulice, Alfredo M. Valencia, et al.. (2017). SMARCB1 is required for widespread BAF complex–mediated activation of enhancers and bivalent promoters. Nature Genetics. 49(11). 1613–1623. 185 indexed citations
16.
Juan, Liran, Mingxiang Teng, Tianyi Zang, et al.. (2014). The personal genome browser: visualizing functions of genetic variants. Nucleic Acids Research. 42(W1). W192–W197. 7 indexed citations
17.
Wang, Guohua, Ke Qi, Yuming Zhao, et al.. (2013). Identification of regulatory regions of bidirectional genes in cervical cancer. BMC Medical Genomics. 6(Suppl 1). S5–S5. 17 indexed citations
18.
Teng, Mingxiang, Yadong Wang, Guohua Wang, et al.. (2011). Prioritizing single-nucleotide variations that potentially regulate alternative splicing. BMC Proceedings. 5(S9). S40–S40. 5 indexed citations
19.
Jiang, Qinghua, Yangyang Hao, Guohua Wang, et al.. (2010). Prioritization of disease microRNAs through a human phenome-microRNAome network. BMC Systems Biology. 4(S1). S2–S2. 335 indexed citations
20.
Jiang, Qinghua, Yadong Wang, Yangyang Hao, et al.. (2008). miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Research. 37(Database). D98–D104. 1130 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026